Literature DB >> 25800007

Mechanisms Regulating Acquisition of Platelet-Derived Factor V/Va by Megakaryocytes.

Jacqueline M Gertz1, Beth A Bouchard1.   

Abstract

Factor Va serves as the nonenzymatic protein cofactor for the prothrombinase complex, which converts prothrombin to thrombin in the events leading to formation of a hemostatic plug. Several observations support the concept that platelet-derived factor V/Va is physically and functionally distinct and plays a more important role in thrombin generation at sites of vascular injury as compared to its plasma counterpart. Platelet-derived factor V/Va is generated following endocytosis of the plasma-derived molecule by the platelet precursor cells, megakaryocytes, via a two receptor system consisting of low density lipoprotein (LDL) receptor-related protein-1 (LRP-1) and an unidentified specific "binding site". More recently, it was suggested that a cell surface-expressed β-galactoside binding protein, galectin-8, was involved in factor V endocytosis. Endocytosed factor V is trafficked through the cell and retailored prior to its storage in α-granules. Given the essential role of platelet-derived factor Va in clot formation, understanding the cellular and molecular mechanisms that regulate how platelets acquire this molecule will be important for the treatment of excessive bleeding or clotting.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  FACTOR V; LRP-1; MEGAKARYOCYTES; PLATELETS; THROMBIN

Mesh:

Substances:

Year:  2015        PMID: 25800007     DOI: 10.1002/jcb.25163

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  3 in total

1.  Identifying and enriching platelet-producing human stem cell-derived megakaryocytes using factor V uptake.

Authors:  Xiuli Sim; Danuta Jarocha; Vincent Hayes; Hayley A Hanby; Michael S Marks; Rodney M Camire; Deborah L French; Mortimer Poncz; Paul Gadue
Journal:  Blood       Date:  2017-04-28       Impact factor: 22.113

2.  Whole blood thrombin generation is distinct from plasma thrombin generation in healthy volunteers and after severe injury.

Authors:  Julia R Coleman; Ernest E Moore; Jason M Samuels; Joshua J Ryon; Jesse T Nelson; Alexander Olson; Sandi Caus; Matthew G Bartley; Navin G Vigneshwar; Mitchell J Cohen; Anirban Banerjee; Christopher C Silliman; Saulius Butenas
Journal:  Surgery       Date:  2019-09-13       Impact factor: 3.982

3.  Whole Blood Thrombin Generation in Severely Injured Patients Requiring Massive Transfusion.

Authors:  Julia R Coleman; Ernest E Moore; Jason M Samuels; Mitchell J Cohen; Christopher C Silliman; Arsen Ghasabyan; James Chandler; Saulius Butenas
Journal:  J Am Coll Surg       Date:  2021-02-04       Impact factor: 6.532

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.